RAS Dialogue Blog
Join the discussion! Post comments, ask questions, and share information with RAS experts. Subscribe to receive notifications when a new RAS Dialogue article is posted.
-
New type of bifunctional molecules perturb K-Ras interactions with membranes
Drs. Johannes Morstein and Kevan Shokat describe their new and unique bifunctional drugs that bind to both KRAS and the plasma membrane.
-
KRAS somatic cancer-driver mutations in endometriosis without cancer: towards a molecular classification for endometriosis?
Drs. Yong, Orr, and Anglesio discuss how they found KRAS mutations—usually seen in cancer—in endometriosis tissue.
-
Oncogene turned bystander - How molecular context shapes KRas oncogenicity
Olesja Popow and Kevin Haigis share their insight into the persistent question of why KRAS mutations drive cancers in some tissues and not in others.
-
RAS Chat: An Interview with Kevan Shokat and Ziyang Zhang
Drs. Kevan Shokat and Ziyang Zhang discuss their work targeting the KRAS G12R and G12S mutations, and give their thoughts on the history and future of RAS research.
-
Consensus on the RAS Dimerization Hypothesis
Consensus on the RAS Dimerization Hypothesis